https://www.selleckchem.com/products/sf2312.html
"LTFs" with improvement in glycaemic control used a higher number of different anti-hyperglycaemic agents (P less then 0.001) and their dosages of metformin increased (P less then 0.05) when compared with "LTFs" without improvement or "LTFs" with satisfactory glycaemic control. Cholesterol-, LDL-cholesterol- and triglyceride-concentrations decreased during the 12-30 month follow-up period (P less then 0.05) in "LTFs" with improved glycaemic control, but not in the other groups. "LTFs" with T2D who had poor glycaemic control seemed to req
লাইক
মন্তব্য করুন
শেয়ার করুন
